HOPO THERAPEUTICS, INC. — Federal Contracts, Awards & Government Contractor Profile

About HOPO THERAPEUTICS, INC.

HOPO Therapeutics is a clinical-stage pharmaceutical company developing novel therapeutics to prevent and treat the toxic effects of heavy metal exposure. The company has received significant funding and partnerships from the U.S. government and is advancing toward its vision of a future without heavy metal poisoning.

Development of investigational, orally-administered chelating agentsResearch on treatments for heavy metal toxicity, including radioactive materials like uranium and plutoniumClinical trial development and managementRegulatory strategy and drug development expertise

Recent Federal Awards

Award	Agency	Amount	Date
DEVELOPMENT OF HOPO-101 AS AN MCM (MEDICAL COUNTERMEASURE) DECORPORATION AGENT FOR THE TREATMENT OF INDIVIDUAL	Department of Health and Human Services	$14.2M

Is this your company?

Claim HOPO THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim HOPO THERAPEUTICS, INC. & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.